1. Котов А.С., Андрюхина О.М., Матюк Ю.В. и др. Оптический неврит и миелит у подростка: оптикомиелит Девика или рассеянный склероз? Неврологический журнал 2015;20(6):35-40. [Kotov A.S., Andryukhina O.M., Matyuk Yu.V. et al. Optic neuritis and myelitis in an adolescent: optical neuromyelitis or multiple sclerosis? Nevrologicheskiy zhurnal = Neurological Journal 2015;20(6):35-40. (In Russ.)].
2. Луцик В.Н., Котов А.С., Борисова М.Н. и др. Оптикомиелит Девика у ребенка. Неврологический журнал 2017;22(4): 205-10. [Lutsik V.N., Kotov A.S., Borisova M.N. et al. Optical neuromyelitis in a child. Nevrologicheskiy zhurnal = Neurological Journal 2017;22(4):205-10. (In Russ.)].
3. Abboud H., Petrak A., Mealy M. et al. Treatment of acute relapses in neuromyelitis optica: steroids alone versus steroids plus plasma exchange. Mult Scler 2016;22(2):185-92. https://doi.org/10.1177/1352458515581438.
4. Bizzoco E., Lolli F., Repice A.M. et al. Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution. J Neurol 2009;256(11):1891-8. https://doi.org/10.1007/s00415-009-5171-x.
5. Coutinho A.E., Chapman K.E. The antiinflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol Cell Endocrinol 2011;335(1):2-13. https://doi.org/10.1016/j.mce.2010.04.005.
6. Wingerchuk D.M. Neuromyelitis optica spectrum disorders: diagnosis and treatment. J Neuroophthalmol 2011;31(4):292.
7. Jacob A., Matiello M., Weinshenker B.G. et al. Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients. Arch Neurol 2009;66(9):1128-33. https://doi.org/10.1001/archneurol.2009.175.
8. Jiao Y., Fryer J.P., Lennon V.A. et al. Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica. Neurology 2013;81(14):1197-204. https://doi.org/10.1212/WNL.0b013e3182a6cb5c.
9. Killian J.M., Bressler R.B., Armstrong R.M., Huston D.P. Controlled pilot trial of monthly intravenous cyclophosphamide in multiple sclerosis. Arch Neurol 1988;45(1):27-30. PMID: 3276298.
10. Mandler R.N., Ahmed W., Dencoff J.E. Devic’s neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine. Neurology 1998;51(4):1219-20. PMID: 9781568.
11. Matiello M., Jacob A., Wingerchuk D.M., Weinshenker B.G. Neuromyelitis optica. Curr Opin Neurol 2007;20(3):255-60. https://doi.org/10.1097/WCO.0b013e32814f1c6b.
12. Oh J., Levy M. Neuromyelitis optica: an antibody-mediated disorder of the central nervous system. Neurol Res Int 2012;2012:460825. https://doi.org/10.1155/2012/460825.
13. Pandit L. Neuromyelitis optica spectrum disorders: an update. Ann Indian Acad Neurol 2015;18(suppl 1):S11-5. https://doi.org/10.4103/0972-2327.164816.
14. Sherman E., Han M. Acute and chronic management of neuromyelitis optica spectrum disorder. Curr Treat Options Neurol 2015;17(11):48. https://doi.org/10.1007/s11940015-0378-x.
15. Wingerchuk D.M., Banwell B., Bennett J.L. et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 2015;85(2):177-89. https://doi.org/10.1212/WNL.0000000000001729.
16. Wingerchuk D.M. Neuromyelitis optica: effect of gender. J Neurol Sci 2009;286(1-2): 18-23. https://doi.org/10.1016/j.jns.2009.08.045.
17. Zaffaroni M., Italian Devic’s Study Group. Cerebrospinal fluid findings in Devic’s neuromyelitis optica. Neurol Sci 2004;25(suppl 4):S368-70. PMID: 15727236.